Abstract:The increasing prevalence of diabetes has led to reducing hyperglycemia through mechanisms other than the conventional mechanism, such as α-amylase and α-glucosidase inhibition. In recent years, medicinal drugs focusing on inhibiting dipeptidyl peptidase IV (DPP IV) and protein tyrosine phosphatase 1B (PTP1B) enzymes have emerged and are being used for type 2 diabetes management. DPP IV inhibitors reduce blood glucose levels by preventing the degradation of incretin hormones such as glucagon-like peptide and glucose-dependent insulinotropic polypeptide. PTP1B has also been known to play a crucial role in reducing insulin resistance and is one of the most promising targets for managing Type 2 diabetes. Inhibition of these two enzymes is also expected to benefit other metabolic conditions such as cancer, obesity, lowered immunity, etc. The existing synthetic DPP IV and PTP1B inhibitors have been known to cause side effects. Inhibitors from natural sources are expected to be safer. The search for PTP1B inhibitors is especially necessary since the primary treatment for type 2 diabetes is to reduce insulin resistance. None of the existing PTP1B inhibitors are clinically well-approved to date. Hence, searching for antihyperglycemic components from natural sources such as foods has become a pressing need. This review has attempted to collate and analyze the existing scientific evidence to identify plant foods and their phytochemicals with in vitro and in vivo DPP IV and PTP1B inhibitory activity comprehensively. With further scientific validation and safety studies, the identified phytochemicals could be used for pharmacological applications. The foods and their extracts could be advantageous in formulating functional foods and diets suitable for type 2 diabetes, along with other physiological benefits.

Advance in dietary polyphenols as dipeptidyl peptidase-IV inhibitors to alleviate type 2 diabetes mellitus: aspects from structure-activity relationship and characterization methods

Design, Synthesis and Biological Evaluation of Novel Pyrimidinedione Derivatives As DPP-4 Inhibitors.

Dipeptidyl Peptidase IV(DPP IV): a Novel Emerging Target for the Treatment of Type 2 Diabetes

The Potential DPP-4 Inhibitors from Xiao-Ke-An Improve the Glucolipid Metabolism Via the Activation of AKT/GSK-3β Pathway.

Recent Advances in Non-Peptidomimetic Dipeptidyl Peptidase 4 Inhibitors: Medicinal Chemistry and Preclinical Aspects

Novel DPP-4 Inhibitors Against Diabetes

Synthesis, structure-activity relationship, and pharmacophore modeling studies of pyrazole-3-carbohydrazone derivatives as dipeptidyl peptidase IV inhibitors.

Dietary polyphenols as antidiabetic agents: Advances and opportunities

Identification of Diverse Dipeptidyl Peptidase IV Inhibitors Via Structure-Based Virtual Screening

Anti-diabetic and anti-obesity: Efficacy evaluation and exploitation of polyphenols in fruits and vegetables

Synthesis and Evaluation of Novel Xanthone Derivatives As Potent Dipeptidyl Peptidase-4 Inhibitors

Preparation, structural properties, and in vitro and in vivo activities of peptides against dipeptidyl peptidase IV (DPP-IV) and α-glucosidase: a general review

Discovery of Food-Derived Dipeptidyl Peptidase IV Inhibitory Peptides: A Review

Exploration of the inhibitory mechanisms of trans-polydatin/resveratrol on α-glucosidase by multi-spectroscopic analysis, in silico docking and molecular dynamics simulation

Food-derived dipeptidyl peptidase IV inhibitory peptides: Production, identification, structure-activity relationship, and their potential role in glycemic regulation

Plant Foods and Their Phytochemicals as DPP IV and PTP1B Inhibitors for Blood Glucose Regulation: A Review

In Silico Exploration of Phytochemicals as Potential Drug Candidates against Dipeptidyl Peptidase-4 Target for the Treatment of Type 2 Diabetes

The development of bioactive peptides from dietary proteins as a dipeptidyl peptidase IV inhibitor for the management of type 2 diabetes

Natural phenolic compounds potentiate hypoglycemia via inhibition of Dipeptidyl peptidase IV

A comprehensive review on the antidiabetic activity of flavonoids targeting PTP1B and DPP-4: a structure-activity relationship analysis

Research Advances on Dipeptidyl Peptidase IV Inhibitors